Literature DB >> 21755457

Selective inhibition of leukotriene receptor BLT-2 reduces vascular oxidative stress and improves endothelial function in ApoE-/- mice.

Friedrich Felix Hoyer1, Lisa Albrecht, Georg Nickenig, Cornelius Müller.   

Abstract

Atherosclerosis is a chronic inflammatory disease and represents the main cause of death in the industrialized world. Metabolites of the arachidonic acid derived from the 5-lipoxygenase pathway are known as leukotrienes that mediate various inflammatory processes during atherogenesis. Leukotriene B4 elicits the overexpression of several proinflammatory proteins, promotes chemotaxis and foam cell formation via BLT receptors. Currently, little is known about the implications of the BLT2 receptor in atherogenesis. Here, we tested whether selective inhibition of this receptor influences the progression of atherosclerosis in mice. Apolipoprotein-E deficient mice were fed a high-fat, cholesterol-rich diet to create atherosclerotic conditions (each group n=9). Simultaneously, mice received the pharmacologic BLT2 inhibition (Ly) by intraperitoneal injection every second day 5 mg/kg bw or vehicle. After 8 weeks, mice were killed and experiments were performed. Vascular superoxide release was diminished in mice treated with Ly compared with the control group (68±15 vs 131±20 RLU, P=0.01), as measured by L012 assay. Next, endothelial function was assessed by organ chamber experiments. Endothelial-dependent relaxation was improved in mice treated with the BLT2 receptor antagonist. To determine whether selective inhibition of the BLT2 receptor affects the atherosclerotic plaque growth, immunohistochemical stainings of the aortic root were performed. Oil red O staining revealed no significant differences between both groups (36±3% vs 38±3%). Monocyte infiltration into the vessel wall was analyzed using Moma-2 staining. No significant differences were observed between both groups (31±3% vs 34±2%). Selective inhibition of the BLT2 receptor in mice reduces the release of vascular reactive oxygen species and improves endothelial function in mice. Further experiments are necessary in order to obtain tissue-specific and mechanistical insights.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21755457     DOI: 10.1007/s11010-011-0995-y

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  19 in total

1.  Leukotriene B4 stimulates human monocyte-derived dendritic cell chemotaxis.

Authors:  Eun Ha Shin; Ha Young Lee; Yoe-Sik Bae
Journal:  Biochem Biophys Res Commun       Date:  2006-07-28       Impact factor: 3.575

2.  Leukotriene B4 receptors BLT1 and BLT2: expression and function in human and murine mast cells.

Authors:  Katherine A Lundeen; Binggang Sun; Lars Karlsson; Anne M Fourie
Journal:  J Immunol       Date:  2006-09-01       Impact factor: 5.422

3.  Leukotriene B4 signaling through NF-kappaB-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia.

Authors:  Magnus Bäck; De-xiu Bu; Robert Bränström; Yuri Sheikine; Zhong-Qun Yan; Göran K Hansson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-17       Impact factor: 11.205

4.  Leukotriene B4 receptor antagonism reduces monocytic foam cells in mice.

Authors:  Robert J Aiello; Patricia-Ann Bourassa; Saralyn Lindsey; Weifan Weng; Ann Freeman; Henry J Showell
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-03-01       Impact factor: 8.311

5.  Inhibition of atherogenesis in BLT1-deficient mice reveals a role for LTB4 and BLT1 in smooth muscle cell recruitment.

Authors:  Eric A Heller; Emerson Liu; Andrew M Tager; Sumita Sinha; Jesse D Roberts; Stephanie L Koehn; Peter Libby; Elena Rabkin Aikawa; Ji Qiu Chen; Paul Huang; Mason W Freeman; Kathryn J Moore; Andrew D Luster; Robert E Gerszten
Journal:  Circulation       Date:  2005-07-26       Impact factor: 29.690

Review 6.  Prostaglandins and leukotrienes: advances in eicosanoid biology.

Authors:  C D Funk
Journal:  Science       Date:  2001-11-30       Impact factor: 47.728

7.  Blockade of airway inflammation and hyperresponsiveness by inhibition of BLT2, a low-affinity leukotriene B4 receptor.

Authors:  Kyung-Jin Cho; Ji-Min Seo; YoungHyun Shin; Min-Hyuk Yoo; Choon-Sik Park; Shin-Hwa Lee; Yoon-Seok Chang; Sang-Heon Cho; Jae-Hong Kim
Journal:  Am J Respir Cell Mol Biol       Date:  2009-05-15       Impact factor: 6.914

8.  Role of leukotriene B4 receptors in the development of atherosclerosis: potential mechanisms.

Authors:  Krishnaprasad Subbarao; Venkatakrishna R Jala; Steven Mathis; Jill Suttles; Wolfgang Zacharias; Jasimuddin Ahamed; Hydar Ali; Michael T Tseng; Bodduluri Haribabu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-12-01       Impact factor: 8.311

9.  Mechanism of endothelial cell NADPH oxidase activation by angiotensin II. Role of the p47phox subunit.

Authors:  Jian-Mei Li; Ajay M Shah
Journal:  J Biol Chem       Date:  2003-01-30       Impact factor: 5.157

Review 10.  Leukotriene receptors: crucial components in vascular inflammation.

Authors:  Magnus Bäck
Journal:  ScientificWorldJournal       Date:  2007-09-01
View more
  4 in total

1.  Platelet microparticles are internalized in neutrophils via the concerted activity of 12-lipoxygenase and secreted phospholipase A2-IIA.

Authors:  Anne-Claire Duchez; Luc H Boudreau; Gajendra S Naika; James Bollinger; Clémence Belleannée; Nathalie Cloutier; Benoit Laffont; Raifish E Mendoza-Villarroel; Tania Lévesque; Emmanuelle Rollet-Labelle; Matthieu Rousseau; Isabelle Allaeys; Jacques J Tremblay; Patrice E Poubelle; Gérard Lambeau; Marc Pouliot; Patrick Provost; Denis Soulet; Michael H Gelb; Eric Boilard
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-23       Impact factor: 11.205

2.  Macrophage 12(S)-HETE Enhances Angiotensin II-Induced Contraction by a BLT2 (Leukotriene B4 Type-2 Receptor) and TP (Thromboxane Receptor)-Mediated Mechanism in Murine Arteries.

Authors:  Tamas Kriska; Anja Herrnreiter; Sandra L Pfister; Adeniyi Adebesin; John R Falck; William B Campbell
Journal:  Hypertension       Date:  2021-11-17       Impact factor: 10.190

Review 3.  Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7.

Authors:  Magnus Bäck; William S Powell; Sven-Erik Dahlén; Jeffrey M Drazen; Jilly F Evans; Charles N Serhan; Takao Shimizu; Takehiko Yokomizo; G Enrico Rovati
Journal:  Br J Pharmacol       Date:  2014-07-12       Impact factor: 8.739

4.  Anti-inflammatory action of ethanolic extract of Ramulus mori on the BLT2-linked cascade.

Authors:  Geun-Soo Park; Jeong-Keun Kim; Jae-Hong Kim
Journal:  BMB Rep       Date:  2016-04       Impact factor: 4.778

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.